Related references
Note: Only part of the references are listed.The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer
He Ma et al.
BIOMOLECULES (2023)
The evolving tumor microenvironment From cancer initiation to metastatic outgrowth
Karin E. de Visser et al.
CANCER CELL (2023)
The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment
Asumi Iesato et al.
THYROID (2023)
Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types
Bingjie Guo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2023)
Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer
Kathy Matuszewska et al.
GYNECOLOGIC ONCOLOGY (2022)
Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK pathway
Peng Nan et al.
CANCER LETTERS (2022)
Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis
Kazuhisa Kitami et al.
MATRIX BIOLOGY (2022)
PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells
Kenny Misael Calvillo-Rodriguez et al.
ONCOIMMUNOLOGY (2022)
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Ralf-Peter Czekay et al.
CANCERS (2022)
Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion
Yvette N. Hlophe et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-beta signal activation in pancreatic ductal adenocarcinoma
Kazuki Matsumura et al.
TRANSLATIONAL ONCOLOGY (2022)
Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities
Jiarui Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1
Jack Lawler
SEMINARS IN CANCER BIOLOGY (2022)
Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma
Chang Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Thrombospondin-4 mediates hyperglycemia- and TGF-beta-induced inflammation in breast cancer
Santoshi Muppala et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells
Yu Shi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Correlation between Oxidative Stress and Transforming Growth Factor-Beta in Cancers
Jinwook Chung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
IL-12 Family Cytokines in Cancer and Immunotherapy
Bhalchandra Mirlekar et al.
CANCERS (2021)
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
Madison Pereira et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Functions of Thrombospondin-1 in the Tumor Microenvironment
Sukhbir Kaur et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
High Levels of Expression of Cartilage Oligomeric Matrix Protein in Lymph Node Metastases in Breast Cancer Are Associated with Reduced Survival
Konstantinos S. Papadakos et al.
CANCERS (2021)
Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity
Albin Jeanne et al.
CANCERS (2021)
Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer
Jasmine Gajeton et al.
CANCERS (2021)
Targeted Thrombospondin-1 Expression in Ocular Vascular Development and Neovascularization
Christine M. Sorenson et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1
Veronica Morandi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy
Zijing Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization
Kai Wang et al.
DRUG DISCOVERY TODAY (2021)
Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer
Monika Kosacka et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake
Kathy Matuszewska et al.
CANCERS (2021)
Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer
Junki Harada et al.
IN VIVO (2021)
Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway
Masato Yoshihara et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
Tessa Y. S. Le Large et al.
ONCOLOGIST (2020)
Tumor-Associated Macrophages: Recent Insights and Therapies
Jiawei Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
Analyses of VEGFC/VEGF-D expressions, density and endothelial lymphatic proliferation in salivary gland neoplasms
Keila Martha Amorim Barroso et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells
S. Balint et al.
SCIENCE (2020)
Tumour vasculature: Friend or foe of oncolytic viruses?
Lisa A. Santry et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Extracellular Vesicles Are Key Regulators of Tumor Neovasculature
Naoya Kuriyama et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)
Marco Rusnati et al.
ANGIOGENESIS (2019)
Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease
Joanne E. Murphy-Ullrich
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2019)
Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model
Maria K. Tveitaras et al.
PLOS ONE (2019)
Tumor-Associated Lymphatic Vessel Features and Immunomodulatory Functions
Laure Garnier et al.
FRONTIERS IN IMMUNOLOGY (2019)
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
Chenxi Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
Kathy Matuszewska et al.
CLINICAL CANCER RESEARCH (2019)
Thrombospondins Differentially Regulate Proteins Involved in Arterial Remodeling
M. M. Kassem et al.
PHYSIOLOGICAL RESEARCH (2019)
Integration of pro- and anti-angiogenic signals by endothelial cells
Shideh Kazerounian et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Joanne E. Murphy-Ullrich et al.
MATRIX BIOLOGY (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
Qing Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Pericytes Elicit Resistance to Vemur1afenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGF beta 1 Axis
Alessandro Prete et al.
CLINICAL CANCER RESEARCH (2018)
Thrombospondin-4 mediates TGF-β-induced angiogenesis
S. Muppala et al.
ONCOGENE (2017)
Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis
Emelie Englund et al.
ONCOTARGET (2017)
TCR Signal Strength and T Cell Development
Nicholas R. J. Gascoigne et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 32 (2016)
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness
Julie Leca et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
E. Englund et al.
ONCOGENE (2016)
Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1
D. Pinessi et al.
THROMBOSIS RESEARCH (2016)
Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47
Erica V. Stein et al.
SCIENTIFIC REPORTS (2016)
Thrombospondin-1,-2 and-5 have differential effects on vascular smooth muscle cell physiology
Alex Helkin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer
Samantha Russell et al.
FASEB JOURNAL (2015)
The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation
Shawn Stapleton et al.
JOURNAL OF CONTROLLED RELEASE (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
David R. Soto-Pantoja et al.
CANCER RESEARCH (2014)
Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep skin carcinogenesis
Rainer Kunstfeld et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
CD47 Signaling Regulates the Immunosuppressive Activity of VEGF in T Cells
Sukhbir Kaur et al.
JOURNAL OF IMMUNOLOGY (2014)
Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury
Y. Zhao et al.
MUCOSAL IMMUNOLOGY (2014)
Coevolution of Solid Stress and Interstitial Fluid Pressure in Tumors During Progression: Implications for Vascular Collapse
Triantafyllos Stylianopoulos et al.
CANCER RESEARCH (2013)
Effect of Tumor Microenvironment on Tumor VEGF During Anti-VEGF Treatment: Systems Biology Predictions
Stacey D. Finley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems
Min Wu et al.
JOURNAL OF THEORETICAL BIOLOGY (2013)
The perivascular niche regulates breast tumour dormancy
Cyrus M. Ghajar et al.
NATURE CELL BIOLOGY (2013)
Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation
Thomas W. Miller et al.
MATRIX BIOLOGY (2013)
Long-Term Gene Therapy with Thrombospondin 2 Inhibits TGF-β Activation, Inflammation and Angiogenesis in Chronic Allograft Nephropathy
Christoph Daniel et al.
PLOS ONE (2013)
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer
Amy E. McCart Reed et al.
VIRCHOWS ARCHIV (2013)
Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments
Linh Nguyen et al.
BMC CANCER (2012)
Monocytes as effector cells: Activated Ly-6Chigh mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells
Patricia Leiriao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
INTERSTITIAL FLUID AND LYMPH FORMATION AND TRANSPORT: PHYSIOLOGICAL REGULATION AND ROLES IN INFLAMMATION AND CANCER
Helge Wiig et al.
PHYSIOLOGICAL REVIEWS (2012)
Induction of CD36 and Thrombospondin-1 in Macrophages by Hypoxia-Inducible Factor 1 and Its Relevance in the Inflammatory Process
Dolores Ortiz-Masia et al.
PLOS ONE (2012)
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and-2
Patrick R. Lawler et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Lymphatic vessel density as a predictor of lymph node metastasis and its relationship with prognosis in urothelial carcinoma of the bladder
Mi Zhou et al.
BJU INTERNATIONAL (2011)
CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
Manuel Koch et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer
Jae Yong Cho et al.
CLINICAL CANCER RESEARCH (2011)
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes
Claus Cursiefen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Thrombospondin-1: Multiple Paths to Inflammation
Zenaida Lopez-Dee et al.
MEDIATORS OF INFLAMMATION (2011)
The Thrombospondins
Josephine C. Adams et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Thrombospondin-4 Regulates Vascular Inflammation and Atherogenesis
Ella G. Frolova et al.
CIRCULATION RESEARCH (2010)
Chemoattractant Receptors and Lymphocyte Egress from Extralymphoid Tissue: Changing Requirements during the Course of Inflammation
Meghan N. Brown et al.
JOURNAL OF IMMUNOLOGY (2010)
Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1
Elizabeth A. Scheef et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Konstantin Gaengel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The effect of thrombospondin-1 on breast cancer metastasis
Karen O. Yee et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker
Tsuyoshi Sugiura et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Thrombospondin-1-induced Apoptosis of Brain Microvascular Endothelial Cells Can Be Mediated by TNF-R1
Tanya A. Rege et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer
James Greenaway et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
Jeff S. Isenberg et al.
NATURE REVIEWS CANCER (2009)
Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours
Sarah Jane Lunt et al.
BMC CANCER (2008)
Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells
Gema Martin-Manso et al.
CANCER RESEARCH (2008)
Thrombospondins in cancer
S. Kazerounian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms
Subhra K. Biswas et al.
JOURNAL OF IMMUNOLOGY (2008)
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
C. Kut et al.
BRITISH JOURNAL OF CANCER (2007)
Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1)
James Greenaway et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node
Gabriele Hintzen et al.
JOURNAL OF IMMUNOLOGY (2006)
Attenuation of retinal vascular development and neovascularization in transgenic mice over-expressing thrombospondin-1 in the lens
Zhifeng Wu et al.
DEVELOPMENTAL DYNAMICS (2006)
Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components
E. Ioachim et al.
BMC CANCER (2006)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function
E Pluskota et al.
BLOOD (2005)
Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins
FH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Endothelial/pericyte interactions
A Armulik et al.
CIRCULATION RESEARCH (2005)
Endogenous thrombospondin-1 is not necessary for proliferation but is pen-nissive for vascular smooth muscle cell responses to platelet-derived growth factor
JS Isenberg et al.
MATRIX BIOLOGY (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2
B Margosio et al.
BLOOD (2003)
Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas
CK Oh et al.
JOURNAL OF DERMATOLOGY (2003)
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer
PO Van Trappen et al.
BRITISH JOURNAL OF CANCER (2002)
Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism
LC Armstrong et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior
ZQ Li et al.
JOURNAL OF CELL BIOLOGY (2002)
Thrombospondin-1 differentially regulates release of IL-6 and IL-10 by human monocytic cell line U937
Y Yamauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice
J Lawler et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma
M Skobe et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism
T Hawighorst et al.
EMBO JOURNAL (2001)
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
SJ Mandriota et al.
EMBO JOURNAL (2001)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)
Tumor angiogenesis
M Detmar
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2000)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
B Jimenez et al.
NATURE MEDICINE (2000)
Share Paper
